These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10709673)

  • 1. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
    Stoner GD; Budd GT; Ganapathi R; DeYoung B; Kresty LA; Nitert M; Fryer B; Church JM; Provencher K; Pamukcu R; Piazza G; Hawk E; Kelloff G; Elson P; van Stolk RU
    Adv Exp Med Biol; 1999; 470():45-53. PubMed ID: 10709673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.
    van Stolk R; Stoner G; Hayton WL; Chan K; DeYoung B; Kresty L; Kemmenoe BH; Elson P; Rybicki L; Church J; Provencher K; McLain D; Hawk E; Fryer B; Kelloff G; Ganapathi R; Budd GT
    Clin Cancer Res; 2000 Jan; 6(1):78-89. PubMed ID: 10656435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study.
    Arber N; Kuwada S; Leshno M; Sjodahl R; Hultcrantz R; Rex D;
    Gut; 2006 Mar; 55(3):367-73. PubMed ID: 16150858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exisulind: Aptosyn, FGN 1, Prevatac, sulindac sulfone.
    Drugs R D; 2004; 5(4):220-6. PubMed ID: 15230629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac.
    Keller JJ; Offerhaus GJ; Polak M; Goodman SN; Zahurak ML; Hylind LM; Hamilton SR; Giardiello FM
    Gut; 1999 Dec; 45(6):822-8. PubMed ID: 10562579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.
    Winde G; Schmid KW; Brandt B; Müller O; Osswald H
    Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
    Labayle D; Fischer D; Vielh P; Drouhin F; Pariente A; Bories C; Duhamel O; Trousset M; Attali P
    Gastroenterology; 1991 Sep; 101(3):635-9. PubMed ID: 1650315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
    Giardiello FM; Hamilton SR; Krush AJ; Piantadosi S; Hylind LM; Celano P; Booker SV; Robinson CR; Offerhaus GJ
    N Engl J Med; 1993 May; 328(18):1313-6. PubMed ID: 8385741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.
    Spagnesi MT; Tonelli F; Dolara P; Caderni G; Valanzano R; Anastasi A; Bianchini F
    Gastroenterology; 1994 Feb; 106(2):362-6. PubMed ID: 8299902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.
    Nugent KP; Farmer KC; Spigelman AD; Williams CB; Phillips RK
    Br J Surg; 1993 Dec; 80(12):1618-9. PubMed ID: 8298943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with sulindac of adenomatous polyps in familial polyposis].
    Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL
    Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer?
    Tonelli F; Valanzano R; Messerini L; Ficari F
    J Surg Oncol; 2000 May; 74(1):15-20. PubMed ID: 10861602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exisulind, a selective apoptotic antineoplastic drug.
    Goluboff ET
    Expert Opin Investig Drugs; 2001 Oct; 10(10):1875-82. PubMed ID: 11772293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry.
    Fernández-López F; Conde-Freire R; Cadarso-Suárez C; García-Iglesias J; Puente-Domínguez JL; Potel-Lesquereux J
    Eur J Surg; 2001 May; 167(5):375-81. PubMed ID: 11419555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
    Samadder NJ; Neklason DW; Boucher KM; Byrne KR; Kanth P; Samowitz W; Jones D; Tavtigian SV; Done MW; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Davis R; Topham MK; Lynch P; Strait E; McKinnon W; Burt RW; Kuwada SK
    JAMA; 2016 Mar 22-29; 315(12):1266-75. PubMed ID: 27002448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of sulindac on the pathology of colorectal remnant polyps of familial adenomatous polyposis (FAP) patients].
    Li J; Lv YM; Jin Z; Cui RL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):371-3. PubMed ID: 16086054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.
    Pasricha PJ; Bedi A; O'Connor K; Rashid A; Akhtar AJ; Zahurak ML; Piantadosi S; Hamilton SR; Giardiello FM
    Gastroenterology; 1995 Sep; 109(3):994-8. PubMed ID: 7657130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case.
    Esaki M; Matsumoto T; Mizuno M; Kobori Y; Yoshimura R; Yao T; Iida M
    Dis Colon Rectum; 2002 Oct; 45(10):1397-402; discussion 1402-6. PubMed ID: 12394442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.